IT1397357B1 - Formulazioni in gel in dose fissa a base di derivati dell'artemisinina - Google Patents

Formulazioni in gel in dose fissa a base di derivati dell'artemisinina

Info

Publication number
IT1397357B1
IT1397357B1 ITMI2009A001133A ITMI20091133A IT1397357B1 IT 1397357 B1 IT1397357 B1 IT 1397357B1 IT MI2009A001133 A ITMI2009A001133 A IT MI2009A001133A IT MI20091133 A ITMI20091133 A IT MI20091133A IT 1397357 B1 IT1397357 B1 IT 1397357B1
Authority
IT
Italy
Prior art keywords
fixed dose
gel formulations
dose based
artemisinin derivatives
artemisinin
Prior art date
Application number
ITMI2009A001133A
Other languages
English (en)
Inventor
Felicia Cisale
Luciano Villanova
Azzurra Villanova
Alessandro Merendino
Gianluca Fasiello
Original Assignee
Lachifarma Srl Lab Chimico Farmaceutico Salentino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lachifarma Srl Lab Chimico Farmaceutico Salentino filed Critical Lachifarma Srl Lab Chimico Farmaceutico Salentino
Priority to ITMI2009A001133A priority Critical patent/IT1397357B1/it
Priority to AP2010005305A priority patent/AP2010005305A0/en
Publication of ITMI20091133A1 publication Critical patent/ITMI20091133A1/it
Application granted granted Critical
Publication of IT1397357B1 publication Critical patent/IT1397357B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
ITMI2009A001133A 2009-06-26 2009-06-26 Formulazioni in gel in dose fissa a base di derivati dell'artemisinina IT1397357B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITMI2009A001133A IT1397357B1 (it) 2009-06-26 2009-06-26 Formulazioni in gel in dose fissa a base di derivati dell'artemisinina
AP2010005305A AP2010005305A0 (en) 2009-06-26 2010-06-24 Fixed doses gel formulations based on artemisinin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001133A IT1397357B1 (it) 2009-06-26 2009-06-26 Formulazioni in gel in dose fissa a base di derivati dell'artemisinina

Publications (2)

Publication Number Publication Date
ITMI20091133A1 ITMI20091133A1 (it) 2010-12-27
IT1397357B1 true IT1397357B1 (it) 2013-01-10

Family

ID=42084469

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001133A IT1397357B1 (it) 2009-06-26 2009-06-26 Formulazioni in gel in dose fissa a base di derivati dell'artemisinina

Country Status (2)

Country Link
AP (1) AP2010005305A0 (it)
IT (1) IT1397357B1 (it)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008098586A1 (en) * 2007-02-13 2008-08-21 Dafra Pharma N.V. Pharmaceutical carrier composition and pharmaceutical composition

Also Published As

Publication number Publication date
AP2010005305A0 (en) 2010-06-30
ITMI20091133A1 (it) 2010-12-27

Similar Documents

Publication Publication Date Title
CY2018030I1 (el) Φαρμακοτεχνικη μορφη 514
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
NO20075628L (no) Farmasøytiske formuleringer
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
ATE493119T1 (de) Pharmazeutische zusammensetzung
IT1391222B1 (it) Dispositivo ortopedico da associare all'esterno di un osso
SMT201400069B (it) Formulazione farmaceutica
BRPI0810439A2 (pt) Formulações farmacêuticas contendo derivados de ácido lipóico
DK2381988T3 (da) Medikamentadministrationsanordning
RU2493831C3 (ru) Фармацевтические композиции
BRPI0921654A2 (pt) formulação farmacêutica
ATE547093T1 (de) Schäumbare mundpflegezusammensetzung
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
FR2968310B1 (fr) Compositions a base de 1,1,1,4,4,4-hexafluorobut-2-ene et de 3,3,4,4,4-pentafluorobut-1-ene
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
SMT201500052B (it) Formulazioni medicinali in aerosol migliorate
BRPI0912656A2 (pt) formulação farmacêutica sólida
FI20080348A0 (fi) Uudenlainen farmaseuttinen formulaatio
ZA201007197B (en) Raloxifene pharmaceutical formulations
FR2958166B1 (fr) Compositions pharmaceutiques fortement dosees en biotine
BRPI0814658A2 (pt) Composição farmacêutica líquida estável
BRPI0913709A2 (pt) "formulação farmacêutica"